Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives FDA's Overreach on Compounded Peptides The Food and Drug Administration will hold a meeting this summer to consider easing restrictions on more than a half dozen peptide injections, a group of unapproved therapies that have become popular Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law The Peptide Craze Part 2: BPC 157, NAD and the Truth Behind the Longevity Molecule Hype